Where Innovative Science and Market Access Meet

Market access advice from market access leaders

LatticePoint is a boutique consulting firm that focuses on pricing and market access for innovative medicines and medical devices. LatticePoint is led by former industry market access leaders who understand how to plan for the political, scientific, and financial realities that will be pivotal in negotiating product access. We work with biopharma companies and investors to help define, negotiate, and defend the value of their products in key markets around the world.

''Access is a game of experience''

Big or small, we adapt to you

Our clients consist of investors and companies in the pre-commercial, commercial, and post-LOE stage across a variety of therapeutic areas and indications, including oncology, rare diseases, cell and gene therapies, radiopharmaceuticals, and many other orphan and non-orphan areas. Whether you need support in fundraising, in-licensing, launching a new medicine or evolving your access team to meet the demands of the future, we have the experience to help you optimize the outcome.

We understand our clients’ needs because we’ve been there.

Our team has significant experience in biomedical and economic sciences, industry, venture capital and negotiating on behalf of clients in various countries. Our work is used for product commercialization, investment valuations, licensing and M&A due diligence.

Over 40 years of industry experience

Supported product access in over 60 markets worldwide

Over 60 clients served worldwide

We have a multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers who have negotiated on behalf of our clients. A quality that is unique in the industry; that’s what we do..